Asia-Pacific ADME Toxicology Testing Market to Reach USD 1,210.28 million with an 11.3% CAGR
Asia-Pacific ADME toxicology testing market is expected to gain substantial growth in the
forecast period of 2021-2028. Data Bridge Market Research analyzes that the
market is growing at a CAGR of 11.3% in the forecast period and is expected to
reach USD 1,210.28 million by 2028. Increasing demand for toxicology testing
products and rising investments in R&D by key market players are major
drivers expected to propel the growth of the market in the forecast period.
Key Pointers Covered
in Asia-Pacific ADME Toxicology Testing Market Industry Trends and Forecast to 2028
·
Market
Size
·
Market
New Sales Volumes
·
Market
Replacement Sales Volumes
·
Market
Installed Base
·
Market
By Brands
·
Market
Procedure Volumes
·
Market
Product Price Analysis
·
Market
Regulatory Framework and Changes
·
Market
Shares in Different Regions
·
Recent
Developments for Market Competitors
·
Market
Upcoming Applications
·
Market
Innovators Study
Get sample copy of
the report:
Benefits of
Considering this Report:
·
This
report is compiled using a vigorous and thorough research methodology. Data
Bridge Market Research is also known for its data accuracy and granular market
reports.
·
A
complete picture of the competitive scenario of Asia-Pacific ADME Toxicology
Testing Market is depicted by this report.
·
The
report consists of a vast amount of data about the recent product and
technological developments in the markets.
·
The
insights in the report are easy to understand and include a graphical
representation of the numbers in the form of histograms, bar graphs, pie
charts, etc.
Asia-Pacific ADME
Toxicology Testing Market Scope and Market Size
Asia-Pacific ADME
toxicology testing market is segmented on the basis of technology, product
type, test, method, application, end user, and distribution channel. The growth
among segments helps you analyze niche pockets of growth and strategies to
approach the market and determine your core application areas and the
difference in your target markets.
·
On the
basis of technology, the Asia-Pacific ADME toxicology testing market is
segmented into cell culture, high throughput, molecular imaging, and omics
technology. The cell culture segment is expected to dominate the market in 2021
owing to increasing research and development activities along with
technological advancements.
·
On the
basis of product type, the Asia-Pacific ADME toxicology testing market is
segmented into instruments, assays & reagents, accessories and software
solutions. In 2021, assays & reagents segment is expected to dominate the
Asia-Pacific ADME toxicology testing market due to increase in rate of late
stage drug failure, and rise in need of novel drug molecules are predicted to
dominate the market.
·
On the
basis of test, the Asia-Pacific ADME toxicology testing market is segmented
into in-vivo and in-vitro. In 2021, in-vitro segment is expected to dominate
the Asia-Pacific ADME toxicology testing market due to surging levels of
investment by the government and private organisations for the growth of the
healthcare industry across the globe are predicted to dominate the market.
·
On the
basis of method, the Asia-Pacific ADME toxicology testing market is segmented
into cellular assay, biochemical assay, in-silica and ex-vivo. In 2021,
cellular assay segment is expected to dominate the Asia-Pacific ADME toxicology
testing market due to increase in rate of late stage drug failure and
technological advancement.
·
On the
basis of application, the Asia-Pacific ADME toxicology testing market is
segmented into systemic toxicity, renal toxicity, hepato toxicity, neuro
toxicity and others. In 2021, systemic toxicity segment is expected to dominate
the Asia-Pacific ADME toxicology testing market due to an increase in awareness
among the patients regarding the benefits of ADME toxicology testing.
·
On the
basis of end user, the Asia-Pacific ADME toxicology testing market is segmented
into biopharmaceutical companies, contract research organizations, academic and
research institute and others. In 2021, biopharmaceutical companies segment is
expected to dominate the Asia-Pacific ADME toxicology testing market due to the
rise in the need of novel drug molecules for toxicology testing.
·
On the
basis of distribution channel, the Asia-Pacific ADME toxicology testing market
is segmented into direct tender and others. In 2021, the direct tender segment
is expected to dominate the Asia-Pacific ADME toxicology testing market due to
new recent developments, and trade regulations are predicted to dominate the
market.
https://www.databridgemarketresearch.com/reports/asia-pacific-adme-toxicology-testing-market
Some of the key questions answered in this
report:
·
How has the Asia-Pacific ADME Toxicology Testing
Market performed so far and how will it perform in the coming years?
·
What are the key regional markets?
·
What is the breakup of the market based on the
procedure?
·
What is the breakup of the market based on the
injury location?
·
What is the breakup of the market based on the
end user?
·
What are the various stages in the value chain
of the industry?
·
What are the key driving factors and challenges
in the industry?
·
What is the structure of the Asia-Pacific ADME
Toxicology Testing Market and who are the key players?
·
What is the degree of competition in the
industry?
Market Analysis and
Insights: Asia-Pacific ADME Toxicology Testing Market
·
ADME refers to
the absorption, distribution, metabolism and elimination of drugs or chemicals
in and from the body. ADME testing plays a vital role in the drug development
process. The testing enables pharmaceutical companies to reduce their drug
discovery time, cost, and test complications.
·
The ADME
toxicology testing market is growing in the forecast year due to several
reasons, such as the rising players in the market and availability of advanced
products. Along with this, manufacturers are engaged in R&D activity for
launching novel products in the market.
·
Stringent rules
and regulations of the government along with high cost of testing may hamper
the ADME toxicology testing market growth in the forecast period.
·
ADME is a
critical piece in drug development studies, which helps determine the viability
of a drug. Toxicology study is a crucial part of drug development used to
characterize a drug's toxicity profile by identifying its impact on organ
structure/ functionality. The study provides critical information and knowledge
used by regulatory agencies to prevent or reduce the likelihood that a disease
or other negative health outcome would occur. The food and Drug Administration
has issued several guidance documents for industry such as safety testing of
drug metabolites, In vitro metabolism and transporter-mediated drug-drug
interaction studies, clinical drug interactions studies.
Asia-Pacific ADME
Toxicology Testing Market Country Level Analysis
Countries covered in the
Asia-Pacific ADME toxicology testing market report are Japan, China, India,
Australia, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines,
Vietnam, and Rest of Asia-Pacific.
Asia-Pacific ADME
Toxicology Testing Market Share Analysis
The ADME toxicology testing
market competitive landscape provides details by competitor. Details included
are company overview, company financials, revenue generated, market potential,
investment in research and development, new market initiatives, production
sites and facilities, company strengths and weaknesses, product launch, product
trials pipelines, product approvals, patents, product width and breadth,
application dominance, and technology lifeline curve. The above data points
provided are only related to the company’s focus related to Asia-Pacific ADME
toxicology testing market.
Key player in
Asia-Pacific ADME Toxicology Testing Market
The major companies which are
dealing in the Asia-Pacific ADME toxicology testing market are Promega
Corporation, Lonza, AAT Bioquest, Inc., Thermo Fisher Scientific Inc., Corning
Incorporated, Charles River Laboratories, LABCYTE INC., BioIVT, Takara Bio
Inc., Agilent Technologies, Inc., PromoCell GmbH, Merck KGaA, and Bio-Rad
Laboratories, Inc., among others.
MAJOR TOC OF THE REPORT
·
Chapter
One: Introduction
·
Chapter
Two: Market Segmentation
·
Chapter
Three: Market Overview
·
Chapter
Four: Executive Summary
·
Chapter
Five: Premium Insights
·
Chapter
Six: Asia-Pacific ADME Toxicology Testing Market Share by Product &
Procedure type
Get TOC Details:
https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-adme-toxicology-testing-market
Top Trending Reports:
·
https://www.databridgemarketresearch.com/reports/global-medical-clothing-market
·
https://www.databridgemarketresearch.com/reports/global-poultry-diagnostics-market
·
https://www.databridgemarketresearch.com/reports/global-remote-patient-monitoring-and-care-market
·
https://www.databridgemarketresearch.com/reports/global-cold-plasma-market
·
https://www.databridgemarketresearch.com/reports/global-neurosurgery-market
·
https://www.databridgemarketresearch.com/reports/global-aesthetic-devices-market
·
https://www.databridgemarketresearch.com/reports/global-x-ray-detectors-market
About Us:
Data Bridge
Market Research set forth
itself as an unconventional and neoteric Market research and consulting firm
with unparalleled level of resilience and integrated approaches. We are determined
to unearth the best market opportunities and foster efficient information for
your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Comments
Post a Comment